Register for our free email digests:
Latest From Altor BioScience Corp.
The Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.
The Obama Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Partner-ready oncology assets cut across diverse fields, including drug conjugates, vaccines and cancer metabolism, with many likely to become part of early-stage deals with shared risk.
- Drug Delivery
- Therapeutic Areas
- Metabolic Disorders
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Nectid Inc.
- Senior Management
- Veena Rao, Pres. & CEO
- Contact Info
Phone: (609) 945-3938
116 Village Blvd.
Princeton, NJ 08540
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.